Logo Medical XPRT
Companies
Products
Services
Software
Training
Applications
Sign in
List your business

Advertising options
  1. Home
  2. News
  3. influenza human
Show results for
Products
Services

Companies

News
Articles
Downloads

Refine by
Date

  • Older

Influenza Human Articles & Analysis

4 news found

H5N1 Antibodies and Antigens for Research Applications

H5N1 Antibodies and Antigens for Research Applications

Some isolated influenza A viruses cause severe disease in poultry and, in rare cases, in humans. Sometimes the virus is transmitted from wild waterfowl to poultry, which can lead to outbreaks or cause human influenza pandemics. H5N1 is a subtype of influenza A virus and belongs to the genus Alpha ...

ByCreative Diagnostics


Universal flu vaccine pioneer EnGen Bio announces a registered equity crowdfunding campaign, in partnership with WeFunder.

Universal flu vaccine pioneer EnGen Bio announces a registered equity crowdfunding campaign, in partnership with WeFunder.

The unique genetic nature of the influenza virus poses a challenge to researchers focused on influenza treatment and vaccination. ...

ByEnGen Bio LLC


EnGen Bio announces a registered equity crowdfunding campaign, in partnership with WeFunder.

EnGen Bio announces a registered equity crowdfunding campaign, in partnership with WeFunder.

Seasonal flu causes 50,000–250,000 deaths worldwide annually, causing the World Health Organization to declare the development of a universal flu vaccine as an urgent need in its Global Influenza Strategy (2019–2030) report. The unique nature and genetic makeup of the influenza virus poses a challenge to researchers focused on ...

ByEnGen Bio LLC


Imaxio receives scientific advice from the European Medicines Agency (EMA) for its influenza vaccine candidate IMX836

Imaxio receives scientific advice from the European Medicines Agency (EMA) for its influenza vaccine candidate IMX836

Imaxio, a biotech company specializing in immunology, announces today that it has received scientific advice from the European Medicines Agency (EMA) for IMX836, its vaccine candidate dedicated to the prevention of influenza in humans. This first scientific advice reinforces Imaxio’s plan to start, by early 2018, a phase I clinical trial involving IMX836. ...

ByIMAXIO S.A.

  • Previous
  • Next
Need help finding the right suppliers?Try XPRT Sourcing. Let the XPRTs do the work for you
Back to top
About Medical XPRT

Medical XPRT is a global marketplace with solutions and suppliers for the medical sector, with product catalogs, articles, industry events, publications & more.

Channels

Solutions

  • Medical XPRT Industry Products
  • Medical XPRT Industry Software
  • Medical XPRT Industry Training
  • Medical XPRT Industry Services
  • Medical XPRT Industry Applications

Latest

  • Medical XPRT Industry News
  • Medical XPRT Industry Events

Publications

  • Medical XPRT Industry Articles
  • Medical XPRT Industry Books
  • Medical XPRT Industry Magazines
  • Medical XPRT Industry Downloads
  • Medical XPRT Industry Videos

Companies

  • Medical XPRT Industry Companies

  • FAQs
  • Company sitemap
  • Category sitemap
Medical XPRT is part of XPRT Media All Rights Reserved.
Terms
Privacy
  • Medical XPRT RSS List
Our sites:
Environmental XPRT
Agriculture XPRT
Energy XPRT
XPRT